Business ❯ Healthcare ❯ Pharmaceuticals

Acquisitions

Vaccine Development Novo Nordisk Johnson & Johnson Biogen Organon-Dermavant Ophthalmology Merck KGaA Sanofi-Dren Bio Agreement AstraZeneca Merck Eli Lilly and Verve Therapeutics Sanofi Alkermes US WorldMeds Pfizer Novartis-Avidity Acquisition Apogee Therapeutics Metsera Cipla Market Expansion Melinta Therapeutics Merck and Cidara Acquisition Eris Lifesciences Gilead Sciences Sanofi and Dynavax GSK Acquisition of RAPT Therapeutics Eli Lilly Telix Pharmaceuticals Digital Pathology Neurocrine Biosciences Eli Lilly & Co. Edgewise Therapeutics Mergers and Acquisitions Jazz Pharmaceuticals Strategic Partnerships Grünenthal

6 ARTICLES

last mo.

Telix to Acquire German Isotope Maker ITM in Up to $2.35 Billion Deal

The transaction is intended to lock in supplies of lutetium-177, actinium-225 and terbium-161, speed commercial rollout, with up to $700 million in payments tied to regulatory approvals and sales milestones.

5 ARTICLES

2mo ago

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

18 ARTICLES

7mo ago

Neurocrine to Acquire Soleno for $2.9 Billion in All-Cash Tender

18 ARTICLES

7mo ago

Lilly to Acquire Centessa for $6.3 Billion to Add Orexin Sleep Drugs

4 ARTICLES

9mo ago

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

11 ARTICLES

9mo ago

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

8 ARTICLES

11mo ago

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

11 ARTICLES

this yr.

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

4 ARTICLES

this yr.

CorMedix Shares Jump After Q3 Beat as Company Lifts 2025 Outlook

4 ARTICLES

last yr.

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

14 ARTICLES

last yr.

Novo Nordisk to Acquire Akero for Up to $5.2 Billion to Expand in MASH

7 ARTICLES

last yr.

DoorDash Signs Multi-Year Deal to Use Serve Robotics’ Sidewalk Bots for Deliveries

3 ARTICLES

last yr.

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M

9 ARTICLES

last yr.

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

9 ARTICLES

last yr.

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Acquisitions

Telix to Acquire German Isotope Maker ITM in Up to $2.35 Billion Deal

Lilly Still Dominates GLP‑1 Market as New Rivals Gain Traction

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

Servier to Buy Edgewise Muscular Dystrophy Unit for Up to $2.65 Billion

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

Neurocrine to Acquire Soleno for $2.9 Billion in All-Cash Tender

Lilly to Acquire Centessa for $6.3 Billion to Add Orexin Sleep Drugs

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Never miss stories about

Acquisitions

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

CorMedix Shares Jump After Q3 Beat as Company Lifts 2025 Outlook

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

Novo Nordisk to Acquire Akero for Up to $5.2 Billion to Expand in MASH

DoorDash Signs Multi-Year Deal to Use Serve Robotics’ Sidewalk Bots for Deliveries

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Never miss stories about

Acquisitions